Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$46.41

0.9 (1.98%)

19:17
08/16/17
08/16
19:17
08/16/17
19:17

Novo Nordisk: SUSTAIN 7 results show superior reduction in HbA1c

Novo Nordisk announced the SUSTAIN 7 trial results, demonstrating that people with type 2 diabetes treated with once-weekly semaglutide experienced superior reduction in HbA1c and body weight compared to treatment with dulaglutide. The 40-week trial investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin. From a mean baseline HbA1c of 8.2%, 0.5 mg semaglutide achieved a statistically significant and superior reduction of 1.5% compared with a reduction of 1.1% with 0.75 mg dulaglutide. People treated with 1.0 mg semaglutide experienced a statistically significant and superior reduction of 1.8% compared with a reduction of 1.4% with 1.5 mg dulaglutide. "The superior glucose control and weight loss achieved with semaglutide compared to dulaglutide in this trial reinforces the unprecedented results observed in the entire SUSTAIN programme" said Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk. "We are excited about the potential of semaglutide to set a new standard for treatment of type 2 diabetes."

  • 18

    Aug

NVO Novo Nordisk
$46.41

0.9 (1.98%)

07/17/17
PIPR
07/17/17
NO CHANGE
Target $102
PIPR
Overweight
Eli Lilly's launch in type 2 diabetes 'remarkable,' says Piper Jaffray
Piper Jaffray analyst Richard Purkiss is highlighting the "remarkable growth story" of Eli Lilly's (LLY) once-weekly GLP-1 agonist Trulicity for type 2 diabetes. At its current pace, Trulicity would become market leader in the GLP-1 space in the early part of next year, surpassing Novo Nordisk's (NVO) Victoza, Purkiss tells investors in a research note. He views Lilly's launch as "quite simply unique in the current climate." Lilly remains one of the analyst's top 2017 picks with an Overweight rating and $102 price target.
04/07/17
04/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lamb Weston (LW) downgraded to Hold from Buy at Stifel with analyst Christopher Growe citing the 44% up move in shares since he launched coverage in November 2016. 2. AstraZeneca (AZN), Novo Nordisk (NVO), Sanofi (SNY), Roche (RHHBY), and Grifols (GRFS) were downgraded to Reduce from Hold at HSBC. 3. AECOM (ACM) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying the company filed an amendment to its credit agreement suggesting likely risk to 2017 earnings, as the filing implies the company would have breached its leverage covenant without an amendment. The analyst is also cautious given the relative obscurity of the filing. Wittmann lowered his price target to $40 from $45 on AECOM shares. 4. Arista Networks (ANET) downgraded to Neutral on valuation at Nomura with analyst Jeffrey Kvaal citing valuation. 5. Maximus (MMS) downgraded to Hold from Buy at Canaccord analyst Richard Close citing expectations of a slow near-term RFP and contract award environment given the recent Trump administration transition. click here.
04/07/17
HSBC
04/07/17
DOWNGRADE
HSBC
Reduce
Novo Nordisk downgraded to Reduce from Hold at HSBC
HSBC analyst Steve McGarry downgraded Novo Nordisk to Reduce to reflect lackluster news flow, valuation risk, and a sector backdrop where US pricing pressure could intensify.
03/21/17
WEDB
03/21/17
INITIATION
WEDB
Outperform
Global Blood Therapeutics coverage assumed with an Outperform at Wedbush
Wedbush analyst Liana Moussatos says that Global Blood Therapeutics' (GBT) GBT440 drug can become the standard of care for sickle cell disease, and he thinks that the stock has not risen adequately following speculation that the company had been approached by Novo Nordisk(NVO) about a takeover. The analyst thinks that the company could be acquired for $73-$87 per share, versus its current price of around $37. Target $73.

TODAY'S FREE FLY STORIES

OPK

OPKO Health

$6.33

0.32 (5.32%)

12:05
09/21/17
09/21
12:05
09/21/17
12:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

OFIX

Orthofix

$47.73

-0.78 (-1.61%)

11:58
09/21/17
09/21
11:58
09/21/17
11:58
Conference/Events
Orthofix management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 26

    Sep

LLEX

Lilis Energy

$3.99

-0.03 (-0.75%)

11:56
09/21/17
09/21
11:56
09/21/17
11:56
Conference/Events
Lilis Energy management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

11:55
09/21/17
09/21
11:55
09/21/17
11:55
General news
Treasury Action: month- and quarter-end are quickly sneaking up »

Treasury Action: month-…

ICFI

ICF International

$50.95

-0.25 (-0.49%)

11:54
09/21/17
09/21
11:54
09/21/17
11:54
Conference/Events
ICF International management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

, BNPQY

BNP Paribas

$39.58

-0.14 (-0.35%)

11:53
09/21/17
09/21
11:53
09/21/17
11:53
Periodicals
German government is favoring Commerzbank-BNP Paribas merger, CNBC says »

The German government is…

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

BNPQY

BNP Paribas

$39.58

-0.14 (-0.35%)

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.03

-0.12 (-0.66%)

11:50
09/21/17
09/21
11:50
09/21/17
11:50
Options
Put buyers active in Marvell as shares tick higher »

Put buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

TSLA

Tesla

$373.91

-1.19 (-0.32%)

11:48
09/21/17
09/21
11:48
09/21/17
11:48
Periodicals
Tesla to stop selling cheapest Model S this weekend, Business Insider says »

Tesla will stop offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FANG

Diamondback Energy

$97.32

3.04 (3.22%)

11:45
09/21/17
09/21
11:45
09/21/17
11:45
Hot Stocks
Diamondback Energy EVP Molnar sells 5,000 shares »

Diamondback Energy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FINL

Finish Line

$9.43

-0.13 (-1.36%)

11:40
09/21/17
09/21
11:40
09/21/17
11:40
Options
Large spread in Finish Line ahead of earnings »

Large spread in Finish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

11:40
09/21/17
09/21
11:40
09/21/17
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

SQ

Square

$28.24

-0.23 (-0.81%)

, INTC

Intel

$37.07

-0.16 (-0.43%)

11:32
09/21/17
09/21
11:32
09/21/17
11:32
Hot Stocks
Square names Intel's Naveen Rao to board »

Square (SQ) announced…

SQ

Square

$28.24

-0.23 (-0.81%)

INTC

Intel

$37.07

-0.16 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 05

    Oct

  • 22

    Oct

WASH

Washington Trust

$53.05

0.15 (0.28%)

11:31
09/21/17
09/21
11:31
09/21/17
11:31
Hot Stocks
Washington Trust increases quarterly dividend by 1c »

The board of Washington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

, CRZBY

Commerzbank

$13.02

0.28 (2.20%)

11:30
09/21/17
09/21
11:30
09/21/17
11:30
Periodicals
UniCredit expresses interest in Commerzbank merger, Reuters reports »

UniCredit recently…

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIH

Oil Services Holders Trust

$24.86

-0.33 (-1.31%)

11:30
09/21/17
09/21
11:30
09/21/17
11:30
Options
Short-term call buyers drilling for profits in Market Vectors Oil Services Fund »

Short-term call buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$98.12

1.92 (2.00%)

11:29
09/21/17
09/21
11:29
09/21/17
11:29
Hot Stocks
Intercept sinks after FDA safety communication cites 19 patient deaths »

The FDA, in its safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOR

ShoreTel

11:25
09/21/17
09/21
11:25
09/21/17
11:25
Hot Stocks
Breaking Hot Stocks news story on ShoreTel »

Gardner Lewis reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$97.46

1.46 (1.52%)

11:25
09/21/17
09/21
11:25
09/21/17
11:25
Periodicals
Equifax CEO to testify to Senate panel on October 4, Bloomberg says »

The Senate Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FSLR

First Solar

$48.85

-0.01 (-0.02%)

, SPWR

SunPower

$7.86

-0.51 (-6.09%)

11:24
09/21/17
09/21
11:24
09/21/17
11:24
Hot Stocks
Before the Move: Watch First Solar, others ahead of ITC decision »

With an ITC Section 201…

FSLR

First Solar

$48.85

-0.01 (-0.02%)

SPWR

SunPower

$7.86

-0.51 (-6.09%)

CSIQ

Canadian Solar

$16.02

-0.69 (-4.13%)

JKS

JinkoSolar

$26.13

-0.16 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNG

Golar LNG

$21.15

0.66 (3.22%)

11:20
09/21/17
09/21
11:20
09/21/17
11:20
Options
Golar LNG calls active as shares see relative strength »

Golar LNG calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
09/21/17
09/21
11:17
09/21/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
09/21/17
09/21
11:16
09/21/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$81.16

-0.64 (-0.78%)

11:15
09/21/17
09/21
11:15
09/21/17
11:15
Options
Capital One put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

11:15
09/21/17
09/21
11:15
09/21/17
11:15
General news
Treasury announced an $88 B 3-pronged package of coupon auctions »

Treasury announced an $88…

PEG

PSEG

$46.31

1.08 (2.39%)

11:10
09/21/17
09/21
11:10
09/21/17
11:10
Conference/Events
PSEG management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 05

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.